Buffett’s DaVita Stock Looks Like A Bull Trap

 | Aug 25, 2020 06:32AM ET

Formerly known as DaVita HealthCare Partners, DaVita (NYSE:DVA) provides kidney dialysis services for patients suffering from chronic kidney failure or end stage renal disease. It was founded in 1994 and went public a year later. As of this writing DaVita’s market cap is close to $10.7 billion. The interesting part is that it is a top 10 holding in the Berkshire Hathaway (NYSE:BRKa) portfolio.

As of Q2 2020, Warren Buffett’s company owns over 38 million DaVita shares worth over $3 billion. And while that is not a huge amount for Berkshire, it represents just over 30% ownership interest in the dialysis services provider.

DaVita stock reached a record high of $92.16 a month ago and is still trading close to that level. Can the uptrend continue or is it time for the bears to show up?